Publicaciones en colaboración con investigadores/as de Universidade de Lisboa (8)

2024

  1. Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): Epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020–2022

    International Journal of Antimicrobial Agents, Vol. 63, Núm. 5

2022

  1. Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)

    Microbiology spectrum, Vol. 10, Núm. 5, pp. e0292722

  2. In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3163-3172

2021

  1. Confronting Ceftolozane-Tazobactam Susceptibility in Multidrug-Resistant Enterobacterales Isolates and Whole-Genome Sequencing Results (STEP Study)

    International Journal of Antimicrobial Agents, Vol. 57, Núm. 2

  2. Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 2, pp. 370-379

  3. In vitro characterization of Pseudomonas aeruginosa recovered in Portugal from low respiratory tract infections in ICU patients (STEP Study)

    FEMS Microbiology Letters, Vol. 368, Núm. 15

2020

  1. In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in intensive care units in Portugal: The STEP multicenter study

    International Journal of Antimicrobial Agents, Vol. 55, Núm. 3

2017

  1. Elucidating constraints for differentiation of major human Klebsiella pneumoniae clones using MALDI-TOF MS

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 2, pp. 379-386